220 results
Page 5 of 11
8-K
EX-10.2
60o0 q6s6
3 May 21
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
8:01am
424B3
fe985t bzog
19 Apr 21
Prospectus supplement
8:07am
424B3
r2bmaf2aputxj 1qp
19 Apr 21
Prospectus supplement
8:07am
424B3
nkl8 yt94ljz8t
19 Apr 21
Prospectus supplement
8:06am
8-K
EX-99.1
hivh5dlc39z5 845rqlt
19 Apr 21
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
8:00am
424B3
2966 7g9b
10 Mar 21
Prospectus supplement
7:31am
424B3
vlcz5e18 fevr54q
16 Feb 21
Prospectus supplement
12:18pm
424B3
93hz6aot
16 Feb 21
Prospectus supplement
12:17pm
8-K
EX-10.4
j5bxm24yps
12 Feb 21
Arch Therapeutics Announces $6.9 Million Private Placement
4:34pm
8-K
EX-10.2
ysi0ewrzmwb4mjmtv w4
12 Feb 21
Arch Therapeutics Announces $6.9 Million Private Placement
4:34pm
8-K
EX-10.1
kf417dj2kxbf0fj0oms
12 Feb 21
Arch Therapeutics Announces $6.9 Million Private Placement
4:34pm
8-K
EX-10.3
d66crhkn ge8j7vtc
12 Feb 21
Arch Therapeutics Announces $6.9 Million Private Placement
4:34pm
8-K
EX-10.5
f28n1jfbf 9prpx
12 Feb 21
Arch Therapeutics Announces $6.9 Million Private Placement
4:34pm
424B3
vyb q0585
8 Feb 21
Prospectus supplement
12:42pm
424B3
s1gnskna fek7q
8 Feb 21
Prospectus supplement
12:41pm
POS AM
m9025fviyycy
26 Jan 21
Prospectus update (post-effective amendment)
4:26pm